tiprankstipranks
Edap Tms S.A. (EDAP)
NASDAQ:EDAP
US Market
Want to see EDAP full AI Analyst Report?

EDAP TMS (EDAP) Earnings Dates, Call Summary & Reports

259 Followers

Earnings Data

Report Date
Aug 26, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.23
Last Year’s EPS
-0.18
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented strong commercial and clinical momentum centered on Focal One Robotic HIFU: record total and HIFU revenue, large YoY increases in procedures and capital sales, improved gross margins, meaningful clinical validation (HIFI-2) and international expansion across multiple indications. Offsetting these positives are near-term financial pressures from higher operating expenses, a wider operating and net loss, cash drawdown and inventory build as the company invests to support growth. The firm mitigated liquidity concerns with an approx. $14M EIB tranche and reiterated 2026 guidance, signaling confidence in continued HIFU growth.
Company Guidance
EDAP reiterated full‑year 2026 guidance calling for core HIFU revenue of $50.0–$54.0 million (implying 34%–45% growth over 2025) and combined non‑core revenue of $22.0–$26.0 million. The company pointed to a strong Q1 that supports this outlook: total revenue $17.8M (+25% YoY vs. $14.3M), HIFU revenue $11.6M (+78% YoY vs. $6.5M) driven by 11 capital sales (10 net placements), a 30% increase in treatment‑driven revenue and U.S. procedure volumes up 53% YoY; gross profit was $8.1M (gross margin 45.7%, +370 bps YoY) with HIFU gross margin 51.4% (vs. 48.6%). Management also disclosed Q1 operating expenses of $15.5M, an operating loss of $7.4M, net loss $9.1M ($0.24/share), inventory of $13.3M (vs. $12.8M at Q4 end), cash $15.0M (vs. $20.5M at Q4 end) and a subsequent ~ $14M EIB tranche received April 20; tariff impact on Q1 was ~ $400k.
Record Quarterly Revenue
Total revenue of $17.8M in Q1 2026, up 25% year-over-year from $14.3M in Q1 2025, driven by strong HIFU performance.
Robust HIFU Growth
Total HIFU revenue of $11.6M in Q1 2026 versus $6.5M in Q1 2025, a 78% year-over-year increase driven by 11 capital sales (vs. 6 prior year) and a 30% increase in treatment-driven revenue.
Surging Procedure Volumes
U.S. Focal One procedure volumes increased 53% year-over-year, reflecting growing physician adoption, expanded training and utilization at existing sites.
Improved Profitability Metrics
Gross profit rose to $8.1M from $6.0M year-over-year; gross margin improved to 45.7% from 42.0% (a 370 basis point increase). HIFU gross margin increased to 51.4% from 48.6%.
Meaningful Commercial Expansion and System Placements
11 capital sales and 10 net placements in the quarter; notable U.S. placements include UPMC cash conversion, Moffitt Cancer Center (10th Florida install), a second system at Mass General Brigham, and first deliveries/ cash sales in Mexico, France, Hungary and Cleveland Clinic London.
Clinical Evidence and Indication Expansion — HIFI‑2
Publication of HIFI-2 (largest prospective salvage study >500 patients) showing 71% of patients avoided hormone deprivation therapy at 30 months overall and 84% in a rigorously selected subgroup; supports reimbursement and guideline alignment for salvage HIFU.
Multi‑Indication Momentum (Endometriosis & BPH)
Focal One capital sales driven by demand across two indications (prostate cancer and deep infiltrating endometriosis); active endometriosis program rollouts in Europe, sponsored symposium with >400 attendees, and ongoing BPH clinical studies with Mount Sinai.
Balance Sheet Support and Corporate Transition
Company became a U.S. domestic issuer effective Jan 1, 2026 and will report in USD; subsequent to quarter end, received ~ $14M second tranche from the European Investment Bank credit facility to strengthen liquidity.
2026 Guidance Reiterated
Reaffirmed full-year 2026 guidance: core HIFU revenue $50M–$54M (implying 34%–45% growth over 2025) and combined noncore revenue $22M–$26M.

EDAP TMS (EDAP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EDAP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 26, 2026
2026 (Q2)
-0.23 / -
-0.175
May 07, 2026
2026 (Q1)
-0.20 / -0.24
-0.213-12.68% (-0.03)
Mar 25, 2026
2025 (Q4)
-0.15 / -0.26
-0.054-372.22% (-0.20)
Nov 06, 2025
2025 (Q3)
-0.25 / -0.15
-0.18418.48% (+0.03)
Aug 28, 2025
2025 (Q2)
-0.21 / -0.17
-0.1781.69% (<+0.01)
May 15, 2025
2025 (Q1)
-0.16 / -0.21
-0.13-63.85% (-0.08)
Mar 27, 2025
2024 (Q4)
-0.11 / -0.05
-0.15164.24% (+0.10)
Nov 07, 2024
2024 (Q3)
-0.16 / -0.18
-0.118-55.93% (-0.07)
Aug 28, 2024
2024 (Q2)
-0.14 / -0.18
-0.141-26.24% (-0.04)
May 16, 2024
2024 (Q1)
-0.12 / -0.13
-0.21639.81% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EDAP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2026
$3.60$4.16+15.72%
Mar 25, 2026
$3.91$3.71-5.12%
Nov 06, 2025
$2.08$1.99-4.33%
Aug 28, 2025
$1.58$1.82+15.19%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Edap Tms S.A. (EDAP) report earnings?
Edap Tms S.A. (EDAP) is schdueled to report earning on Aug 26, 2026, After Close (Confirmed).
    What is Edap Tms S.A. (EDAP) earnings time?
    Edap Tms S.A. (EDAP) earnings time is at Aug 26, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EDAP EPS forecast?
          EDAP EPS forecast for the fiscal quarter 2026 (Q2) is -0.23.